Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Aug;36(8 Pt B):2935-2941.
doi: 10.1053/j.jvca.2022.01.049. Epub 2022 Feb 4.

Characteristics and Outcomes of COVID-19 Patients Supported by Venoarterial or Veno-Arterial-Venous Extracorporeal Membrane Oxygenation

Magued W Haroun  1 , Snehal R Patel  2 , Daniel B Sims  2 , Ulrich P Jorde  2 , Daniel J Goldstein  3 , Omar Saeed  4
Affiliations
Multicenter Study

Characteristics and Outcomes of COVID-19 Patients Supported by Venoarterial or Veno-Arterial-Venous Extracorporeal Membrane Oxygenation

Magued W Haroun et al. J Cardiothorac Vasc Anesth. 2022 Aug.

Abstract

Objectives: Cardiac injury has been reported in up to 20%-to-30% of patients with COVID-19, and severe disease can lead to cardiopulmonary failure. The role of mechanical circulatory support in these patients remains undetermined. The authors here aimed to determine the characteristics and outcomes of patients with COVID-19 requiring venoarterial extracorporeal membrane oxygenation (VA ECMO) or veno-arterial-venous (VAV) ECMO support.

Design and setting: A multicenter, retrospective case series.

Participants: The cohort consisted of adult patients (18 years of age and older) with confirmed COVID-19 requiring VA ECMO or VAV ECMO support in the period from March 1, 2020, to April 30, 2021. Outcomes were recorded until July 31, 2021.

Measurements and main results: To show factors related to death during hospitalization, patients were grouped as survivors and nonsurvivors. Kaplan-Meier analysis was used to estimate 90-day in-hospital mortality. Overall, 37 patients from 12 centers comprised the study cohort. The median patient age was 44 years old (interquartile range [IQR], 35-52), and 12 (32%) were female patients. The duration of ECMO support ranged from 2-to-132 days. At the end of the follow-up period, 13 patients (35%) were discharged or transferred alive, and 24 patients (65%) died during the hospitalization. The cumulative in-hospital mortality at 90 days was 64% (95% confidence interval: 47-81). During the time from intubation to VA ECMO or VAV ECMO initiation (1 day [IQR 0-7.5] v 6 days [IQR 2.5-14], p = 0.0383), body mass index (32 [IQR 26-36] v 37 [IQR 33-40], p = 0.009), and baseline C-reactive protein (7.15 v 38.9 mg/dL, p = 0.009) were higher in those who expired.

Conclusion: Only one-third of the patients with COVID-19 requiring VA ECMO or VAV ECMO survived to discharge. Close monitoring of at-risk patients with early initiation of ECMO with circulatory support may further improve outcomes.

Keywords: COVID-19; VA ECMO; VAV ECMO; circulatory support devices; coronavirus disease 2019; venoarterial extracorporeal membrane oxygenation.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None.

Figures

Fig 1
Fig. 1
Estimated cumulative incidence of in-hospital mortality after initiation of extracorporeal membrane oxygenation (ECMO) for COVID-19 at 90-days was 64% (95%CI: 47-81). The solid line shows the estimated cumulative incidence of in-hospital mortality and the shaded region represents the 95% CI.
Fig 2
Fig. 2
Changes in the configuration of extracorporeal membrane oxygenation among survivors and non-survivors.
See this image and copyright information in PMC

References

    1. COVID-19 dashboard by the Center for Systems Science and Engineering at Johns Hopkins University; 2021. Johns Hopkins Coronavirus Resource Center.https://coronavirus.jhu.edu/map.html?> Available at: Accessed September 15.
    1. Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020;5:831–840. - PubMed
    1. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396:1071–1078. - PMC - PubMed
    1. Saeed O, Tatooles AJ, Farooq M, et al. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J Thorac Cardiovasc Surg. 2021 S0022-5223(21)00801-1. Online ahead of print. - PMC - PubMed
    1. Lebreton G, Schmidt M, Ponnaiah M, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: A multicentre cohort study. Lancet Respir Med. 2021;9:851–862. - PMC - PubMed

Publication types